Quince Therapeutics
QNCX
QNCX
45 hedge funds and large institutions have $1.44M invested in Quince Therapeutics in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
56% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 36
98% less capital invested
Capital invested by funds: $67.5M → $1.44M (-$66M)
Holders
45
Holding in Top 10
–
Calls
$766K
Puts
$10K
Top Buyers
| 1 | +$3.27M | |
| 2 | +$1.78M | |
| 3 | +$1.74M | |
| 4 |
Millennium Management
New York
|
+$1.32M |
| 5 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
+$133K |
Top Sellers
| 1 | -$8.95M | |
| 2 | -$7.54M | |
| 3 | -$3.12M | |
| 4 |
SCM
Superstring Capital Management
New York
|
-$2.88M |
| 5 |
SC
Stempoint Capital
New York
|
-$2.48M |
